SCHEMBL31062425

SCHEMBL31062425

O=C(O)Cc1cccc(-c2cc(F)cc(F)c2)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SUCNR1 Q9BXA5 1/20 0.43
AKR1B1 P15121 2/20 0.40
PTGS2 P35354 3/20 0.39
PTGER1 P34995 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39
CXCL8 P10145 5/20 0.39
AKR1B10 O60218 1/20 0.39
UGT1A9 O60656 1/20 0.39
TRPA1 O75762 1/20 0.39
ABCB11 O95342 1/20 0.39
MT-CO2 P00403 1/20 0.39
TTR P02766 1/20 0.39
ALB P02768 1/20 0.39
UGT1A6 P19224 1/20 0.39
UGT1A1 P22309 1/20 0.39
PTGS1 P23219 1/20 0.39
CXCR1 P25024 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31062441 0.84 SUCNR1 (0.44) SUCNR1AKR1B1PTGS2PTGER1PTGER4
SCHEMBL9890683 0.84 PTGS2 (0.52) AKR1B1PTGS2PTGER1PTGER4PTGER3
SCHEMBL31062516 0.78 PTGDR2 (0.40) AKR1B1PTGS2PTGER1PTGER4PTGER3
SCHEMBL31062293 0.78 FFAR4 (0.47) PTGS2PTGER1PTGER4PTGER3PTGER2
SCHEMBL31062273 0.77 PTGER1 (0.39) SUCNR1AKR1B1PTGS2PTGER1PTGER4
SCHEMBL22798814 0.76 AKR1B1 (0.58) AKR1B1PTGS2CXCL8AKR1B10UGT1A9
SCHEMBL30285770 0.75 CXCL8 (0.53) AKR1B1PTGS2CXCL8AKR1B10UGT1A9
SCHEMBL17838502 0.75 CXCL8 (0.53) AKR1B1PTGS2CXCL8AKR1B10UGT1A9
SCHEMBL9105295 0.75 PTGER1 (0.57) AKR1B1PTGS2PTGER1PTGER4PTGER3
SCHEMBL31339486 0.75 AHR (0.42) ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024168004-A1 BIARYL AMIDE-CONTAINING AGONISTS OF OREXIN RECEPTOR TYPE 2 VERTEX PHARMACEUTICALS INCORPORATED (US) 2024-08-15 WO disclosed